08/13/2024
We’re thrilled to be recognized in Venture Capital Post for our innovative approach to treating peripheral neuropathy. Learn how WinSanTor’s research is bringing new hope to millions with our innovative drug, WST-057, designed to reverse nerve damage.
Read the full article to explore the science behind this game-changing development. Link in bio.